MYH9 can act as a coreceptor for SARS-CoV-2 to enter the host and enhance viral infection by promoting the endocytosis of SARS-CoV-2 dependent on ACE2, but this process does not require the participation of TMPRSS2 and the CatB/L pathway. Here, ACE2 is linked to viral infectious disease.